VGX-1027
Catalog No. A12548
VGX-1027通过抑制Toll样受体4(TLR4)信号传导来显示免疫调节和抗炎活性。
Catalog Num | A12548 |
---|---|
M. Wt | 205.21 |
Formula | C11H11NO3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 6501-72-0 |
Synonyms | GIT 27, VGX1027, GIT27 |
SMILES | C1C(ON=C1C2=CC=CC=C2)CC(=O)O |
VGX-1027通过抑制Toll样受体4(TLR4)信号传导来显示免疫调节和抗炎活性。
In vitro (25°C) | DMSO | 38 mg/mL (185.17 mM) | |
Water | Insoluble | ||
Ethanol | 38 mg/mL (185.17 mM) | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 48.73 mL | 243.65 mL | 487.31 mL |
0.5 mM | 9.75 mL | 48.73 mL | 97.46 mL |
1 mM | 4.87 mL | 24.37 mL | 48.73 mL |
5 mM | 0.97 mL | 4.87 mL | 9.75 mL |
*The above data is based on the productmolecular weight 205.21. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.